Cannabis bioengineering generally involves the use of genetic modifications to scale up the production process of cannabis and its extracts. Cannabinoids such as THC, CBD, and several others present in the cannabis plant matrix only exist in small quantities. This makes it unfit for use on an industrial scale especially in terms of the pharmaceutical use of the product. Cannabinoids are majorly concentrated in trichomes which are short outgrowth on the cannabis bud. This makes the stem, stalk, leaves unusable in terms of getting the necessary cannabinoids. This apparent need led to the introduction of genetic modifications to cannabis cultivation.
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…
Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…
On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…
Is cannabis a miracle cure or a gateway to ruin? We break down the latest…